VYGR Voyager Therapeutics, Inc.
$3.19▲ +0.00%
Healthcare
Other
After hours
$3.19▲ +0.00%
Sep 11, 7:30 PM ET
Volume 276.1K
Avg Volume (10D) 431.1K
Key Metrics & Fundamentals
Market Cap
$196.56M
P/E Ratio
–
Div Yield
–%
52W Range
2.94 - 5.55
% vs 50 MA
-3.38%
% vs 200 MA
-15.22%
RSI-14
42.3
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.31
Free Cash Flow
-$25.84M
Gross Rev
$3.17M
Gross Profit
$3.17M
EBITDA
-$25.48M
COGS
–
Operating Exp
$29.56M
Operating Income
-$26.39M
EBIT
-$26.39M
Pretax Income
-$24.45M
Net Income
-$24.47M
EPS (Diluted)
-0.40
Price & Volume History
Loading chart…
Recent News
Palantir, Voyager-Backed Starlab Seeks ISS Microgravity Research Proposals
MT Newswires · Sep 11, 2026 12:31 PM
Voyager to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 12:00 PM
Voyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 6, 2026 11:10 PM
Voyager Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 8:44 PM
Voyager Reports Second Quarter 2026 Financial and Operating Results
GlobeNewswire · Aug 6, 2026 8:01 PM
Voyager Therapeutics Expects to Start Early Alzheimer's Study in Adults in H2
MT Newswires · Jul 13, 2026 12:35 PM
Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026
GlobeNewswire · Jul 13, 2026 12:01 PM
Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?
Barrons.com · Jul 13, 2026 6:00 AM
Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money
24/7 Wall St. · Jul 2, 2026 1:33 PM
Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside
Insider Monkey · Jun 30, 2026 4:34 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See VYGR's money flow as a full page
Social Sentiment
No Reddit posts found for VYGR.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.